Wedelolactone |
524-12-9 |
7-Methoxy-5,11,12-trihydroxy-coumestan |
UNII-0K6L725GNS |
1,8,9-Trihydroxy-3-methoxycoumestan |
CHEMBL97453 |
0K6L725GNS |
CHEBI:10037 |
1,8,9-Trihydroxy-3-methoxy-6H-benzofuro[3,2-c][1]benzopyran-6-one |
1,8,9-Trihydroxy-3-methoxy-6H-benzofuro[3,2-c]chromen-6-one |
1,8,9-Trihydroxy-3-methoxy-6H-[1]benzofuro[3,2-c]chromen-6-one |
7-Methoxy-5,11,12-trihydroxycoumestan |
Wedelolactone, Eclipta alba |
IKK Inhibitor II, Wedelolactone |
SCHEMBL601220 |
GTPL5551 |
CTK8G3781 |
DTXSID60200408 |
Wedelolactone, analytical standard |
1,8,9-trihydroxy-3-methoxy-benzofuro[3,2-c]chromen-6-one |
HMS2043P19 |
1,8,9-trihydroxy-3-methoxy-[1]benzofuro[3,2-c]chromen-6-one |
HY-N0551 |
ZINC6483512 |
BDBM50096619 |
LMPK12090046 |
MFCD07778564 |
s9042 |
AKOS015897173 |
CCG-208289 |
SMP2_000112 |
5,11,12-Trihydroxy-7-methoxycoumestan |
Wedelolactone, >=98% (HPLC), powder |
SC-67595 |
CS-0009079 |
FT-0698529 |
N2131 |
A14804 |
C10541 |
K00058 |
524W129 |
SR-05000002318 |
Q6586709 |
SR-05000002318-2 |
BRD-K53635676-001-01-5 |
BRD-K53635676-001-02-3 |
Wedelolactone; 7-Methoxy-5,11,12-trihydroxy-coumestan |
1,8,9-trihydroxy-3-methoxy-[1]benzoxolo[3,2-c]chromen-6-one |
Wedelolactone, European Pharmacopoeia (EP) Reference Standard |
1,8,9-Trihydroxy-3-methoxy-benzo[4,5]furo[3,2-c]chromen-6-one |
6H-Benzofuro(3,2-c)(1)benzopyran-6-one, 1,8,9-trihydroxy-3-methoxy- |